North America Drug Delivery Market By Industry Trends and Forecast the Upcoming Opportunities and Threats in the Next 8 Years.

North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024 from USD 501.37 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024.The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Free Report Sample: http://databridgemarketresearch.com/request-a-sample/?dbmr=north-america-drug-delivery-market

Some of the major factors driving the market for North America drug delivery market are rising prevalence of chronic disease such as diabetes, growth of biologics, new product launches, drug innovation, technological advancements and growth in the development of biologics.On the other hand, factors such as side effects and injuries, infections, safety measures regarding the use of devices used for the administration of drug, patent expiry, product recall and patent cliff hampers the growth of the market.

Key Drivers:

Some of the major factors driving the market for North America drug delivery market are rising prevalence of chronic disease such as diabetes, growth of biologics, new product launches, drug innovation, technological advancements and growth in the development of biologics.
An opportunity for the pharmaceutical companies to focus on introducing various products in the market.

Significant growth in the biologics market due to the increased spending by the pharmaceutical companies on biologics.

The development of new drug delivery systems administration of drugs through different routes becomes more efficient and effective.

Inquiry Before Buying: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=north-america-drug-delivery-market

Key Points:

Johnson & Johnson Services, Inc., is going to dominate the North America drug delivery market followed by Novartis AG along with others such as F. Hoffmann-La Roche AG, Pfizer, Inc., GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Nemera, Cima Labs, Inc., Dali Medical Devices, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals DSM Biomedical and Catalent, Inc.among others.

Injectable Drug Delivery market is growing with the highest CAGR.
Globally solid oral is driving the market with highest market share along with highest CAGR.
Tabletis dominating the North America solid oral drug delivery market.

Market Segmentation:

On the basis of route of administration the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug. The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups. The Injectable drug delivery segment is further segmented into devices and formulations.

The devices segment is categorized as conventional injections, self-injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices. The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes. The injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable. In 2017, on the basis of route of administration, oral drug delivery market is expected to dominate the market with 41.0% market share.

The Pulmonary Drug Delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.

For Any Query Talk to Analyst: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=north-america-drug-delivery-market

Ocular drug delivery is segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays. Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.

Nasal drug delivery is segmented into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal. The transdermal topical drug delivery includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sublingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.

On the basis of distribution channel the North America drug delivery market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy. In 2017, the direct tenders segment is expected to dominate the market.

On the basis of end users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others. The hospitals segment dominates the North America drug delivery market with more than 40.0% market share.

Access Full Report: http://databridgemarketresearch.com/reports/north-america-drug-delivery-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.